Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 27, 1997

View Archived Issues

Allergan: Q3 1997 highlights

Incyte: Q3 1997 highlights

Theratechnologies: Q3 1997 highlights

Labopharm: HY1997 highlights

Factor Xa inhibitors from Zeneca for use as anticoagulants/antithrombotics

ARS discloses new 5alpha-reductase inhibitors

Researchers at Janssen/Neurocrine Biosciences develop CRF antagonists

Histamine H3 ligands prepared by James Black Foundation

P&U describes new ergoline derivatives for CNS disorders

Spotlight on smoking cessation therapy

New preclinical data presented on ACEA-1021

SA-4503 offered for licensing by Santen

TOP-53: preclinical antitumor activity and pharmacokinetics

Watson acquires Searle contraceptive products

SciClone presents promising preclinical data for CPX at CF conference

Janssen, Gliatech extend Alzheimer's disease research agreement

Mechanism of action elucidated for anthracycline developed by Sumitomo

Topical antiinflammatory activity of COX-2 inhibitors assessed

Low-molecular-weight selectin inhibitor displays potent antiinflammatory activity

Promising preliminary results reported from pertussis vaccine project

Antiangiogenic agent TNP-470 suppresses tumorigenesis in animal model

Possible MDR-modulating effect described for E-6123, a PAF antagonist

Apoptotic effects described for antiestrogen

Flamel Technologies reports clinical results on Asacard

IL-15 exerts potent antiapoptotic effects in vivo

VIMRxyn enters phase II for treatment of skin diseases

SuperGen files supplemental NDA for Nipent

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...